ÂÜÀòÂÒÂ×

Matthias Kromayer is Managing Partner at MIG Capital. He leads MIG’s activities in the Life Sciences and has been involved in the exits of several biotech companies as well as in three IPOs, of which two at Nasdaq.

Prior to MIG, Matthias was Managing Partner with a strategic consultancy in the Life Sciences sector. In addition, he has own entrepreneurial experience building and running several companies within and outside of the Life Sciences sector. Previously, he was Senior Consultant with an international top management consultancy.

Matthias received training in Biology and Chemistry at Munich University, King’s College London, UK, and Lund Universitet, Sweden, and holds a Ph.D. in Molecular Microbiology from Munich University. He is Alumnus and member of the selection committee of the Studienstiftung des Deutschen Volkes.